QUILT-3.088: NANT Pancreatic Cancer Vaccine
Condition: Metastatic Pancreatic Cancer Interventions: Drug: Gemcitabine; Drug: Nab-paclitaxel; Drug: Aldoxorubicin HCl; Biological: ALT-803; Biological: ETBX-011; Biological: ETBX-021; Biological: ETBX-051; Biological: ETBX-061; Biological: GI-4000; Biological: GI-6207; Biological: GI-6301; Biological: haNK; Drug: Avelumab; Drug: Bevacizumab; Drug: Capecitabine; Drug: Cyclophosphamide; Drug: 5-Fluorouracil; Drug: Leucovorin; Drug: Oxaliplatin Sponsor: NantKwest, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Cancer | Cancer & Oncology | Cancer Vaccines | Eloxatin | Pancreas | Pancreatic Cancer | Research | Vaccines | Xeloda